Skip to main content
. Author manuscript; available in PMC: 2021 Mar 13.
Published in final edited form as: ACS Infect Dis. 2020 Jan 13;6(3):467–478. doi: 10.1021/acsinfecdis.9b00406

Figure 5. Spectroscopic interaction of compound 1 with CysK.

Figure 5.

(A) Scanning absorbance and (B) fluorescence spectra of CysK with no ligand (black), OALS (red), 1 (green), 1,2,4-triazole (blue), and EcP10 (purple). CysK-OALS complex and inhibitor combinations are in dashed lines.